Expression of scavenger receptor CD36 in chronic renal failure patients

Michal Chmielewski1, Ewa Bryl, Lukasz Marzec

  • 1Department of Nephrology, Transplantology and Internal Medicine, Medical University of Gdansk, Gdansk, Poland. chmiel@amg.gda.pl

Artificial Organs
|July 29, 2005
PubMed

Insights

Patients with chronic renal failure (CRF) show higher expression of the scavenger receptor CD36 on monocytes, a potential risk factor for atherosclerosis. Statin therapy was associated with reduced CD36 expression in these patients.

Area of Science:

  • Nephrology
  • Cardiology
  • Immunology

Background:

  • Chronic renal failure (CRF) patients face elevated atherosclerosis risk.
  • Foam cell formation is a key step in atherosclerosis pathogenesis.
  • Scavenger receptor CD36 mediates oxidized low-density lipoprotein uptake, crucial for foam cell formation.

Purpose of the Study:

  • To investigate CD36 scavenger receptor expression on blood monocytes in CRF patients.
  • To assess the relationship between CD36 expression and renal replacement therapy modalities.
  • To evaluate the impact of statin treatment on CD36 expression in CRF.

Main Methods:

  • Flow cytometry was used to measure CD36 expression on monocytes from hemodialysis (HD), peritoneal dialysis (PD), predialysis, and control groups.
  • Lipid peroxidation markers, malondialdehyde (MDA) and 4-hydroxyalkenals (HAE), were quantified.
  • The effect of statin therapy on CD36 expression was analyzed.

Main Results:

  • Monocyte CD36 expression was significantly higher in HD and PD patients compared to controls.
  • Predialysis patients did not show significantly higher CD36 expression than controls.
  • Elevated MDA and HAE levels were found in all CRF subgroups; statin users had lower CD36 expression.

Conclusions:

  • This study is the first to report increased CD36 scavenger receptor expression in CRF patients.
  • Elevated CD36 expression may contribute to accelerated atherogenesis in CRF.
  • Statin therapy may mitigate CD36-related atherosclerosis risk in CRF patients.
Abstract

Related Concept Videos

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Renal Corpuscle01:20

Renal Corpuscle

The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous capillaries...
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...